William L. Ostrander

VP Finance/Corp Secy, Heat Biologics.

Companies

Heat BiologicsChief financial officer Jan 6, 2021 to Dec 9, 2022¹
Heat BiologicsVP Finance/Corp Secy Sep 26, 2019 to Aug 14, 2020²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARHeat Biologics, Chief financial officer
2
SEC EDGARHeat Biologics, VP Finance/Corp Secy